University of Oxford researchers have found honey highly effective for easing common cold and upper respiratory infection symptoms. As a safer, more affordable, and accessible option, it offers a promising alternative to antibiotics—though further clinical trials are essential before widespread adoption.
A 2017 analysis of 198 honey samples detected pesticide traces in 75%, raising concerns. Yet, new evidence from a University of Oxford study, published in BMJ Evidence-Based Medicine on August 18, 2020, suggests honey may surpass conventional treatments for certain conditions.
The researchers highlight honey's role in relieving cold and flu symptoms, positioning it as a cost-effective, safe alternative to antibiotics. With the World Health Organization warning of antibiotic resistance as a global crisis driven by overprescription, they urge physicians to recommend honey to patients where appropriate.
Antibiotics often trigger side effects and contribute to diminishing efficacy, underscoring the need to curb their use. Honey could play a key part in this shift.
Long touted as a traditional remedy for coughs, honey's benefits lacked robust scientific backing until now. Oxford scientists reviewed data from multiple trials on upper respiratory tract infections (URTIs), which affect the nose, sinuses, throat, and larynx.
Their analysis shows honey improves URTI symptoms effectively. Prior studies confirm its ability to combat bacteria like Escherichia coli, Helicobacter pylori, and Salmonella species, with varieties like Malaysian Tualang and New Zealand Manuka proving particularly potent. Still, the team calls for additional rigorous research to solidify honey as a standard treatment.
